Stay updated on BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page
- Check5 days agoChange DetectedRecruitment status updated to indicate no enrollment; new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, the Intervention/Treatment label was standardized, and the revision tag updated to v3.6.0.SummaryDifference0.3%

- Check12 days agoChange DetectedThe page's revision label updates from v3.5.4 to v3.5.5, signaling a small update to the site's revision history.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 for the study record, indicating a metadata/version change in the COMBAT entry. This update does not modify the study content or eligibility details.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page’s footer revision/version indicator has been updated from **Revision: v3.5.0** to **Revision: v3.5.3**.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be an internal version update and does not modify study details or user-facing content.SummaryDifference0.0%

- Check105 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page.